Recent research reveals that microplastics in eyedrops are a widespread emerging contaminant in various commercial formulations. A study conducted in Malaysia investigated 21 different eyedrop products and found that 81% of them contained detectable microplastic particles. Furthermore, these findings highlight a previously unrecognized route of human exposure, particularly for patients using ocular medications long-term.

Characterizing Microplastics in Eyedrops

The study utilized micro-FTIR analysis to identify the chemical composition and morphological features of the contaminants. Polystyrene emerged as the most common polymer, followed by polyamide and polyethylene. Additionally, researchers observed diverse particle shapes such as irregular fragments, fibers, and pellets. The particle abundance varied significantly across categories, with lubricant eyedrops showing the highest contamination levels. For instance, one lubricant reported a mean concentration of 3 particles per milliliter. Consequently, frequent users of these products could be exposed to millions of particles daily. Such data underscore the urgent need for improved manufacturing standards and regulatory oversight to protect ocular health.

Clinical Risks and Exposure Among Patients

The potential health implications of these particles are currently being investigated. However, existing evidence suggests that microplastics can cause physical irritation and trigger inflammation on the ocular surface. Glaucoma patients are especially at risk due to their frequent and chronic use of these medications. Specifically, urban patients face an estimated daily exposure of 0.137 million particles. Moreover, these micro-particles might act as vectors for other chemical toxins, further complicating patient outcomes. Therefore, eye care professionals should remain vigilant as new research emerges regarding the safety of plastic-packaged therapeutics.

Frequently Asked Questions

Which type of eyedrops contained the most microplastics?

According to the study, lubricant eyedrops exhibited the highest concentration of microplastic particles among all tested categories.

Are there specific polymers found in these medications?

Yes, the most commonly identified polymers were polystyrene, polyamide, and polyethylene, which likely originate from the packaging or production process.

Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional endorsement. Always consult a qualified healthcare provider for diagnosis and treatment. Refer to the latest local and national guidelines for clinical practice.

References

Paranjothy B et al. Microplastic contamination in commercial eyedrop products: detection and characterization study. Environ Sci Pollut Res Int. 2026 Mar 22. doi: 10.1007/s11356-026-37664-5. PMID: 41865358.

Wang et al. Microplastics and nanoplastics in the ocular environment: Pathways, toxic effects, and future challenges. PMC. 2025 Aug 07.

Chan AE, Chan D. Microplastic toxicity and its impact on the eye. Optometry Times. 2025 Jun 25.